Search

Your search keyword '"Reiter, Robert E."' showing total 281 results

Search Constraints

Start Over You searched for: Author "Reiter, Robert E." Remove constraint Author: "Reiter, Robert E." Database Unpaywall Remove constraint Database: Unpaywall
281 results on '"Reiter, Robert E."'

Search Results

2. PD42-05 CORRELATING PROSTATE-SPECIFIC MEMBRANE ANTIGEN WITH MOLECULAR PATHWAYS IN TREATMENT NAÏVE PROSTATE CANCER

3. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer

5. MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

6. Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR

7. Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials

8. Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial

9. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

10. A novel prostate cancer subtyping classifier based on luminal and basal phenotypes

11. Abstract 3315: Evaluating biomarker potential of germline genomic factors for predicting clinical outcomes in prostate cancer

12. Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography

14. Data from Autoantibody Landscape in Patients with Advanced Prostate Cancer

17. Supplementary Tables S1-S4 from Autoantibody Landscape in Patients with Advanced Prostate Cancer

20. Supplementary Figures S1-S9 from Autoantibody Landscape in Patients with Advanced Prostate Cancer

24. Supplementary Figures S1-S9 from Autoantibody Landscape in Patients with Advanced Prostate Cancer

25. Supplementary Figures from Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models

26. Supplemental Figures from Fluorescent Image–Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time

27. Supplementary Video S2 from Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models

29. Data from Autoantibody Landscape in Patients with Advanced Prostate Cancer

33. Supplementary Tables S1-S4 from Autoantibody Landscape in Patients with Advanced Prostate Cancer

38. LUNAR : a randomized Phase 2 study of177 Lutetium‐PSMANeoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)

39. External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis

40. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

41. Multimodality Therapies for Localized Prostate Cancer

42. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial

43. Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)

44. The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

45. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study

46. Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity

48. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium

49. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021

50. Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena

Catalog

Books, media, physical & digital resources